Skip to main content
SpringerLink
Log in

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study

  • Original Article
  • Published:
Updates in Surgery Aims and scope Submit manuscript

Abstract

Pseudomyxoma peritonei (PMP) is a rare condition characterized by the intraperitoneal accumulation of mucus derived mostly by appendiceal mucinous neoplasm. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) can offer a favourable overall survival. In this study, we report a single-institute outcomes following CRS and HIPEC in patients with this condition. This is a review of prospectively collected data from 32 patients (11 men and 21 women) affected by PMP of appendiceal origin who underwent CRS and HIPEC from 2008 to 2016 in our Surgical Unit of General and Esophagogastric Surgery. The median age of the patients was 53 years (range 25—77 years). After CRS, all patients underwent HIPEC (mytomicin C 3.3 mg/m2/L and cisplatin 25 mg/m2/L at 41 °C for 60 min) with closed abdomen technique. The median (range) follow-up time for surviving patients was 43 (18–119) months. The median peritoneal cancer index (PCI) was 17. Complete cytoreductive surgery (CC0) was achieved in in 22 patients (69%). The majority of patients (88%) had grade I–II complications, 3 (9%) had grade III complications, and 1 (3%) patient had a grade IV complication. There were no perioperative mortalities. The median hospital stay was 9.5 (range 9–24) days. One year and 5-year overall survival (OS) were 90% and 58%, respectively. Regardless of histotype, disease-free survival was 95% at 1 year and 46% at 5 years. CRS in combination with HIPEC is a feasible treatment strategy and can achieve a satisfactory outcome in patients with PMP of appendiceal origin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Delhorme J-B, Severac F, Averous G, Glehen O, Passot G, Bakrin N, Marchal F, Pocard M, Lo Dico R, Eveno C, Carrere S, Sgarbura O, Quenet F, Ferron G, Goéré D, Brigand C, French National Network of Peritoneal Surface Malignancies (2018) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin. Br J Surg 105:668–676. https://doi.org/10.1002/bjs.10716

    Article  PubMed  Google Scholar 

  2. Sugarbaker PH (2006) New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7:69–76. https://doi.org/10.1016/S1470-2045(05)70539-8

    Article  PubMed  Google Scholar 

  3. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM (1995) Disseminated peritoneal adenomucinosis and peritoneal mucinous adenomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol 19:1390–1408. https://doi.org/10.1097/00000478-199512000-00006

    Article  CAS  PubMed  Google Scholar 

  4. Mehta SS, Bhatt A, Glehen O (2016) Cytoreductive surgery and peritonectomy procedures. Indian J Surg Oncol 7:139–151. https://doi.org/10.1007/s13193-016-0505-5

    Article  PubMed  PubMed Central  Google Scholar 

  5. Halkia E, Tsochrinis A, Vassiliadou DT, Pavlakou A, Vaxevanidou A, Datsis A, Efstathiou E, Spiliotis J (2015) Peritoneal carcinomatosis: Intraoperative parameters in open (Coliseum) versus closed abdomen HIPEC. Int J Surg Oncol 2015:610597. https://doi.org/10.1155/2015/610597

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH (ed) Peritoneal carcinomatosis: principles of management. Cancer treatment and research, vol 82. Springer, Boston, pp 359–374. https://doi.org/10.1007/978-1-4613-1247-5_23

    Chapter  Google Scholar 

  7. Sugarbaker PH, Chang D (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727–731. https://doi.org/10.1007/s10434-999-0727-7

    Article  CAS  Google Scholar 

  8. Yan TD, Links M, Xu ZY, Kam PC, Glenn D, Morris DL (2006) Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms. Br J Surg 93:1270–1276. https://doi.org/10.1002/bjs.5427

    Article  CAS  PubMed  Google Scholar 

  9. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA (2007) Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 245:104–109. https://doi.org/10.1097/01.sla.0000231705.40081.1a

    Article  PubMed  PubMed Central  Google Scholar 

  10. Chua TC, Yan TD, Smigielski ME, Zhu KJ, Ng KM, Zhao J, Morris DL (2009) Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution. Ann Surg Oncol 16:1903–1911. https://doi.org/10.1245/s10434-009-0341-8

    Article  PubMed  Google Scholar 

  11. Elias D, Gilly F, Quenet F, Bereder JM, Sidéris L, Mansvelt B, Lorimier G, Glehen O, Association Française de Chirurgie (2010) Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 36:456–462. https://doi.org/10.1016/j.ejso.2010.01.006

    Article  CAS  PubMed  Google Scholar 

  12. Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IH, Ceelen WP, Pelz JO, Piso P, González-Moreno S, Van Der Speeten K, Morris DL (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449–2456. https://doi.org/10.1200/JCO.2011.39.7166

    Article  PubMed  Google Scholar 

  13. Schneider MA, Eshmuminov D, Lehmann K (2017) Major postoperative complications are a risk factor for impaired survival after CRS/HIPEC. Ann Surg Oncol 24:2224–2232. https://doi.org/10.1245/s10434-017-5821-7

    Article  PubMed  Google Scholar 

  14. Carr NJ, Cecil TD, Mohamed F, Sobin LH, Sugarbaker PH, González-Moreno S, Taflampas P, Chapman S, Moran BJ; Peritoneal Surface Oncology Group International (2016) A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified delphi process. Am J Surg Pathol 40:14–26. https://doi.org/10.1097/PAS.0000000000000535

    Article  Google Scholar 

  15. Shetty S, Natarajan B, Thomas P, Govindarajan V, Sharma P, Loggie B (2013) Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival. Am Surg 79:1171–1176

    Article  Google Scholar 

  16. Munoz-Zuluaga C, Sardi A, King MC, Nieroda C, Sittig M, MacDonald R, Gushchin V (2018) Outcomes in peritoneal dissemination from signet ring cell carcinoma of the appendix treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 26:473–481. https://doi.org/10.1245/s10434-018-7007-3

    Article  PubMed  Google Scholar 

  17. Piso P, Nedelcut SD, Rau B, Königsrainer A, Glockzin G, Ströhlein MA, Hörbelt R, Pelz J (2019) Morbidity and mortality following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: data from the DGAV StuDoQ Registry with 2149 consecutive patients. Ann Surg Oncol 26:148–154. https://doi.org/10.1245/s10434-018-6992-6

    Article  PubMed  Google Scholar 

  18. Raspé C, Flöther L, Schneider R, Bucher M, Piso P (2017) Best practice for perioperative management of patients with cytoreductive surgery and HIPEC. Eur J Surg Oncol 43:1013–1027. https://doi.org/10.1016/j.ejso.2016.09.008

    Article  PubMed  Google Scholar 

  19. Tempfer CB, Solass W, Buerkle B, Reymond MA (2014) Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in a woman with pseudomyxoma peritonei: a case report. Gynecol Oncol Rep 18(10):32–35. https://doi.org/10.1016/j.gore.2014.10.001

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. General and Upper GI Surgery Division, University of Verona, Piazzale Stefani, 1, 37124, Verona, Italy

    Alberto Di Leo, Arianna Corvasce, Jacopo Weindelmayer, Elena Jane Mason, Francesco Casella & Giovanni de Manzoni

Authors
  1. Alberto Di Leo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arianna Corvasce
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jacopo Weindelmayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elena Jane Mason
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Francesco Casella
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Giovanni de Manzoni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alberto Di Leo.

Ethics declarations

Conflict of interest

None of the authors have any conflicts of interest.

Research involving human participants and/or animals

The study was in accordance with the ethical standards of the institutional research committee.

Informed consent

Informed consent was obtained from all individual participants involved.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Di Leo, A., Corvasce, A., Weindelmayer, J. et al. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study. Updates Surg 72, 1207–1212 (2020). https://doi.org/10.1007/s13304-020-00788-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13304-020-00788-5

Keywords

Search

Navigation